Archrock (AROC) and Aquestive Therapeutics held their respective second-quarter earnings calls, providing updates on their financial performance and business outlook. Transcripts and highlights from these calls were made available.

Several companies, including RB Global, Hubbell, and HCA Healthcare, have declared their latest quarterly dividends. Additionally, Eastern Bankshares, Archrock, Hilltop, South State, and Avidia Bancorp announced increases to their quarterly dividends.

An article provides an investment analysis, asking whether Archrock, Inc. (AROC) stock is a good buy at the current time.

Azenta and Archrock both reported financial results that missed their top-line and bottom-line estimates for the recent period. Azenta subsequently updated its FY26 outlook, while Archrock reaffirmed its own for the same fiscal year.

Archrock has announced the timing for its first-quarter 2026 earnings results, while Mene has already reported its fourth-quarter financial performance. These announcements provide updates on the financial activities of both companies.

A summary of the Q4 2025 earnings call for Archrock, Inc. has been released.

Archrock, Inc. released highlights from its Q2 earnings call, detailing key financial results and business updates for the quarter. The summary provided an overview of the company's performance.

Archrock (AROC) has seen gains, attributed to the increasing prices of oil.

Several companies, including Root, Adient, TaskUs, and Maximus, have released their earnings call transcripts or summaries for the first or second quarter of 2026. These reports provide financial updates and insights into their recent performance.

Archrock has announced that its Chief Financial Officer, Douglas Aron, plans to retire from his position by the end of 2026.

Several companies, including Elanco, Super Group, Amprius Technologies, Amgen, and Gilead, have either raised or updated their financial outlooks for fiscal year 2026, with many reporting beats on top-line and bottom-line estimates. These updates include revised revenue projections, EPS guidance, and growth targets.

Mizuho has increased its price target for Archrock (AROC), suggesting a more optimistic forecast for the company's stock value.

Several companies, including Bruker, Lifemd, Carter's, and Clean Harbors, have reaffirmed their financial guidance and outlooks for the 2026 fiscal year. These projections include targets for revenue, adjusted EBITDA, and earnings per share.

Several investment trusts and companies, including Invesco, Neuberger Berman, iRadimed, Magna International, and Federal REIT, have announced their latest dividend payouts to shareholders. These declarations cover various amounts and funds.

Archrock has announced the highlights from its fourth-quarter earnings call, detailing the company's financial performance for the period.

An article provides a preview of Archrock's financial results for the fourth quarter of 2025.